Stockreport

Valneva Announces Sale of Priority Review Voucher for $103 Million [Yahoo! Finance]

Valneva SE - American Depositary Shares  (VALN) 
PDF Food and Drug Administration (FDA) for $103 million (€95 million). The Company was awarded a tropical disease PRV in November 2023 following U.S. FDA approval of IXCHI [Read more]